English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

AbstractThis review explores the intricate relationship between interleukin-6 ( IL-6 ) and sarcopenia, a prevalent condition characterized by progressive skeletal muscle loss, particularly in aging populations. Emphasizing the rising prevalence and health challenges posed by sarcopenia, the paper delves into the multifunctional roles of  IL-6  in immune response, inflammation and inflammaging associated with sarcopenia. Significantly elevated in sarcopenic individuals,  IL-6  prompts an exploration of its molecular impact on muscle wasting. The review critically assesses  IL-6  as a potential biomarker for sarcopenia diagnosis and prognosis while also examining therapeutic interventions targeting  IL-6  signaling pathways, offering a foundation for future research and the development of targeted therapeutic strategies to alleviate the impact of this debilitating condition.

﻿Interleukin-6: Unravelling its role in sarcopenia pathogenesis and exploring therapeutic avenues

Interleukin-6: Unravelling its role in sarcopenia pathogenesis and exploring therapeutic avenues